Harvard Gastroenterology 2026

150 $

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: internists, primary care physicians, gastroenterologists, hepatologists, oncologists, geriatricians, and obstetricians/gynecologists

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: internists, hospitalists, primary care physicians, gastroenterologists, hepatologists, oncologists, geriatricians, and obstetricians/gynecologists

+ Sample video: contact me for sample video

+ Information:

1. Overview

The Comprehensive 2026 Gastroenterology Update

Gastroenterology 2026 is a live online course, using live streaming, electronic Q&A, and other remote learning technologies. 

This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.

Practical, Results-Driven Education

Highlights of the 2026 program include:

  • The newest guidelines for the use of biologics in IBD
  • Therapeutic drug monitoring in IBD treatment
  • Management of the older adult with IBD
  • Updated guidelines for treatment of C. difficile infection
  • Managing GI complications of immunotherapy and anti-neoplastic therapies
  • Improved management of IBS
  • Tips for managing fecal incontinence
  • Management of refractory GERD
  • Optimal surveillance in hereditary GI cancer syndromes
  • Current treatment of H. pylori
  • Updated treatment of HBV and HCV
  • Management of steatotic liver disease in 2026
  • How to diagnose and manage cirrhosis
  • How to improve your adenoma detection rate (ADR)
  • Steps to ensure delivery of high-quality colonoscopic care
  • Techniques to effectively control acute GI bleeding
  • Endoscopic management of obesity
  • When FMT is indicated for treatment
  • New strategies to treat common GI problems
  • A comprehensive update of national guidelines

As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

Education to Optimize Your Patient Outcomes

The evidence-based recommendations provided in this program cover strategies to improve care and outcomes for patients with:

  • IBD
  • GI complications of immunotherapy
  • Microscopic colitis
  • Steatotic liver disease
  • Barrett’s esophagus
  • Eosinophilic esophagitis
  • C. difficile colitis
  • H. pylori infection
  • Alcohol-related liver disease
  • Autoimmune hepatitis
  • IBS
  • Refractory GERD
  • Acute pancreatitis
  • Chronic pancreatitis
  • Celiac disease
  • GI bleeding
  • High risk for colorectal cancer

Recent Advances and Innovations

Clinicians can rely on this program for education on:

  • Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
  • GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
  • Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
  • The stool microbiome: understanding the science behind clinical applications
  • Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
  • Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate
  • Endoscopic approaches to managing obesity
  • Updated treatments for HBV and HCV

This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.

2. Learning Objectives Upon completion of this course, participants will be able to:

  • Interpret major advances in the field of gastroenterology.

  • Incorporate the most up-to-date diagnostic approaches to GI disorders.

  • Identify therapeutic options for GI disorders in an evidence-based manner.

  • Manage patients with both common and rare GI disorders using established guidelines.

3. Target Audience Who Should Participate:

  • Gastroenterologists

  • Internists

  • Hospitalists

  • Surgeons

  • Nurse Practitioners

  • Physician Assistants …and other medical professionals seeking a comprehensive update in Gastroenterology.

Best for internists, hospitalists, primary care physicians, gastroenterologists, hepatologists, oncologists, geriatricians, and obstetricians/gynecologists.

4. Topics

Monday, June 8, 2026

Welcome

Dr. Daniel Chung

8:25-8:30 am

Which Initial Therapy to Choose in Crohn’s Disease?

Dr. Joshua Korzenik

8:30-9:10 am

Which Initial Therapy to Choose in Ulcerative Colitis?

Dr. Ashwin Ananthakrishnan

9:10-9:50 am

Putting It Together: Illustrative IBD Case Presentations

Dr. Kristin Burke

9:50-10:20 am

Panel Q&A

Drs. Ashwin Ananthakrishnan, Joshua Korzenik, and Kristin Burke

10:20-10:35 am

Break

10:35-10:50 am

Management of the Older Adult with IBD

Dr. Bharati Kochar

10:50-11:15 am

IBD in Pregnancy

Dr. Loren Rabinowitz

11:15-11:40 am

Therapeutic Drug Monitoring in IBD

Dr. Adam Cheifetz

11:40 am-12:15 pm

Panel Q&A

Drs. Adam Cheifetz, Bharati Kochar, and Loren Rabinowitz

12:15-12:30 pm

Break

12:30-1:30 pm

How to Manage Microscopic Colitis

Dr. Hamed Khalili

1:30-2:00 pm

GI Complications of Immunotherapy

Dr. Michael Dougan

2:00-2:30 pm

GI Complications of Antineoplastic Therapy

Dr. Shilpa Grover

2:30-3:00 pm

Panel Q&A

Drs. Michael Dougan, Hamed Khalili, and Shilpa Grover

3:00-3:15 pm

Break

3:15-3:30 pm

High-Risk Cancer Surveillance in GI Cancer Syndromes

Dr. Daniel Chung

3:30-4:00 pm

CRC Screening and How to Improve Your ADR

Dr. Ramona Lim

4:00-4:30 pm

Beyond Screening: What to Recommend to Reduce Colorectal Cancer Risk

Dr. Andrew Chan

4:30-5:00 pm

Panel Q&A

Drs. Daniel Chung, Ramona Lim, and Andrew Chan

5:00-5:15 pm

Day 2

Tuesday, June 9, 2026

Barrett’s Esophagus: Whom and How to Treat?

Dr. Douglas Pleskow

8:30-9:10 am

Esophageal Motility Disorders Made Easy

Dr. Barbara Nath

9:10-9:40 am

Management of Refractory GERD

Dr. Norman Nishioka

9:40-10:10 am

Panel Q&A

Drs. Douglas Pleskow, Barbara Nath, and Norman Nishioka

10:10-10:25 am

Break

10:25-10:40 am

Comprehensive Approach to Eosinophilic Esophagitis

Dr. Walter Chan

10:40-11:20 am

Celiac Disease and Gluten Sensitivity: 2026 Practitioner Updates

Dr. Ciaran Kelly

11:20 am-12:05 pm

Panel Q&A

Drs. Walter Chan and Ciaran Kelly

12:05-12:20 pm

Break

12:20-1:30 pm

Making the Diagnosis of IBS

Dr. Kyle Staller

1:30-2:00 pm

Modern Strategies to Treat IBS

Dr. Vikram Rangan

2:00-2:30 pm

Tips to Managing Fecal Incontinence

Dr. Kyle Staller

2:30-2:50 pm

Panel Q&A

Drs. Kyle Staller and Vikram Rangan

2:50-3:05 pm

Break

3:05-3:25 pm

Optimizing the Management of Gastroparesis

Dr. Trisha Pasricha

3:25-3:55 pm

How to Evaluate Small Intestinal Bacterial Overgrowth

Dr. Judy Nee

3:55-4:25 pm

Panel Q&A

Drs. Judy Nee and Trisha Pasricha

4:25-4:40 pm

Day 3

Wednesday, June 10, 2026

Cholestatic Liver Diseases: What’s New in PBC and PSC

Dr. Daniel Pratt

8:30-9:00 am

Update on Autoimmune Hepatitis

Dr. Alan Bonder

9:00-9:30 am

Current Approaches to the Treatment of HBV and HCV

Dr. Michael Curry

9:30-10:00 am

Panel Q&A

Drs. Daniel Pratt, Alan Bonder, and Michael Curry

10:00-10:15 am

Break

10:15-10:30 am

Alcohol-Associated Liver Disease

Dr. Gyongyi Szabo

10:30-11:10 am

The Management of MASLD

Dr. Kathleen Corey

11:10-11:40 am

Panel Q&A

Drs. Gyongyi Szabo and Kathleen Corey

11:40-11:55 am

Break

11:55 am-1:00 pm

How to Workup a Liver Lesion

Dr. Karin Andersson

1:00-1:30 pm

Diagnosis and Routine Management of Cirrhosis

Dr. Michelle Lai

1:30-2:00 pm

Managing Advanced Liver Disease

Dr. Anna Rutherford

2:00-2:40 pm

Panel Q&A

Drs. Anna Rutherford and Karin Andersson

2:40-3:00 pm

Break

3:00-3:15 pm

Best Management Strategies in Acute Pancreatitis

Dr. David Jin

3:15-3:45 pm

Updates in Chronic Pancreatitis

Dr. Sunil Sheth

3:45-4:20 pm

Controversies in the Management of Cystic Lesions of the Pancreas

Dr. Carlos Fernandez-del Castillo

4:20-4:50 pm

Panel Q&A

Drs. David Jin, Sunil Sheth, and Carlos Fernandez-del Castillo

4:50-5:05 pm

Day 4

Thursday, June 11, 2026

Tips to Removing the Difficult Colon Polyp

Dr. Tyler Berzin

8:30-9:10 am

Quality in Colonoscopy: What to Measure and Why It Matters

Dr. Mandeep Sawhney

9:10-9:40 am

Endoscopy and the Anticoagulated Patient

Dr. Kunal Jajoo

9:40-10:10 am

Panel Q&A

Drs. Tyler Berzin, Mandeep Sawhney, and Kunal Jajoo

10:10-10:25 am

Break

10:25-10:40 am

Acute GI Bleeding and Other GI Emergencies

Dr. Linda Lee

10:40-11:20 am

Advances in Endoscopic Surgery for Foregut Disorders

Dr. Kumar Krishnan

11:20-11:50 am

Endoscopic Approaches to Manage Obesity

Dr. Christopher Thompson

11:50 am-12:20 pm

Panel Q&A

Drs. Christopher Thompson, Kumar Krishnan, and Linda Lee

12:20-12:35 pm

Break

12:35-1:45 pm

What’s New in C. Difficile Colitis

Dr. Jessica Allegretti

1:45-2:15 pm

Q&A with Dr. Allegretti

2:15-2:30 pm

New Insights into the Gut Microbiome and Disease

Dr. Ramnik Xavier

2:30-3:00 pm

Current Approach to Diagnosis and Treatment of Helicobacter pylori

Dr. Jay Luther

3:00-3:30 pm

GI Cases to Remember

Dr. Douglas Horst

3:30-4:00 pm

Panel Q&A

Drs. Douglas Horst, Ramnik Xavier, and Jay Luther

4:00-4:15 pm

Reviews

There are no reviews yet.

Be the first to review “Harvard Gastroenterology 2026”

Your email address will not be published. Required fields are marked *

+ 82 = 90
Powered by MathCaptcha